“Bimekizumab Provides Rapid and Sustained Improvements in Scalp and Nail Outcomes in Patients With Moderate to Severe Plaque Psoriasis: 60 Week Results from a Randomized, Double Blinded, Phase 2b Extension Study”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S34. Accessed April 7, 2025. https://skin.dermsquared.com/skin/article/view/761.